Jane Street Group, LLC Ultragenyx Pharmaceutical Inc. Call Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$40.21 - $59.36 $1.07 Million - $1.58 Million	26,600 New	26,600 $1.48 Million
Q1 2022 May 17, 2022	BUY	$62.2 - $84.4 $230,140 - $312,280	3,700 Added 22.42%	20,200 $1.47 Million
Q3 2021 Nov 16, 2021	BUY	$77.92 - $102.4 $109,088 - $143,360	1,400 Added 9.27%	16,500 $1.49 Million
Q1 2021 May 18, 2021	SELL	$106.9 - $167.73 $448,980 - $704,466	-4,200 Reduced 21.76%	15,100 $1.72 Million
Q4 2020 Feb 17, 2021	SELL	$84.4 - $177.39 $75,960 - $159,651	-900 Reduced 4.46%	19,300 $2.67 Million
Q3 2020 Nov 17, 2020	BUY	$72.98 - $90.0 $576,542 - $711,000	7,900 Added 64.23%	20,200 $1.66 Million
Q2 2020 Aug 17, 2020	BUY	$46.91 - $78.22 $576,993 - $962,106	12,300 New	12,300 $962,000

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.15B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.